郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

代谢疾病A Novel and Highly Potent Urotensin II Receptor Antagonist Inhibits Urotensin II-Induced Pressure Response in Mice.

期刊：Journal of cardiovascular pharmacology发表年份：2019作者：Mina Nishi; Kiyoaki Yonesu; Hideki Tagawa; Mikio Kato; Shinji Marumoto; Takahiro Nagayama
阅读更多 →

代谢疾病A Long-Acting PYY3-36 Analog Mediates Robust Anorectic Efficacy with Minimal Emesis in Nonhuman Primates.

期刊：Cell metabolism发表年份：2019作者：Shamina M Rangwala; Katharine D'Aquino; Yue-Mei Zhang; Lindsay Bader; Wilson Edwards; Songmao Zheng; Annette Eckardt; Ann Lacombe; Rebecca Pick; Veronica Moreno; Lijuan Kang; Wenying Jian; Eric Arnoult; Martin Case; Celia Jenkinson; Ellen Chi; Ronald
阅读更多 →

代谢疾病Peptide Oligomerization Memory Effects and Their Impact on the Physical Stability of the GLP-1 Agonist Liraglutide.

期刊：Molecular pharmaceutics发表年份：2019作者：Jameson R Bothe; Alexandra Andrews; Katelyn J Smith; Leo A Joyce; Yogita Krishnamachari; Sandhya Kashi
阅读更多 →

代谢疾病Antidiabetic and cardiovascular beneficial effects of a liver-localized mitochondrial uncoupler.

期刊：Nature communications发表年份：2019作者：Naohide Kanemoto; Takashi Okamoto; Koji Tanabe; Takahiro Shimada; Hitomi Minoshima; Yuya Hidoh; Masashi Aoyama; Takashi Ban; Yusuke Kobayashi; Hikaru Ando; Yuki Inoue; Motohiro Itotani; Seiji Sato
阅读更多 →